Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial

Najmeh Kaffash Farkhad, Alireza Sedaghat, Hamidreza Reihani, Amir Adhami Moghadam, Ahmad Bagheri Moghaddam, Nayereh Khadem Ghaebi, Mohammad Ali Khodadoust, Rashin Ganjali, Amir Reza Tafreshian, Jalil Tavakol‐Afshari

Stem Cell Research & Therapy · 2022 · 57 citations · 35 references

DOIFull text

Open access

References

35